Alterity Therapeutics Files 6-K for Security Quotation
Ticker: PRNAF · Form: 6-K · Filed: Mar 4, 2024 · CIK: 1131343
| Field | Detail |
|---|---|
| Company | Alterity Therapeutics Ltd (PRNAF) |
| Form Type | 6-K |
| Filed Date | Mar 4, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, securities, administrative
Related Tickers: ATH
TL;DR
Alterity Therapeutics filed a 6-K for a securities quotation application, linking to existing S-8 and F-3 filings.
AI Summary
Alterity Therapeutics Limited filed a Form 6-K on March 4, 2024, to incorporate by reference an application for quotation of securities (Exhibit 99.1). This filing is related to their existing Registration Statements on Form S-8 and Form F-3, which are used for registering securities offerings.
Why It Matters
This filing indicates administrative steps related to the company's securities, potentially impacting how their shares are traded or registered.
Risk Assessment
Risk Level: low — This is a routine administrative filing related to securities quotation and does not appear to contain new material financial or operational information.
Key Players & Entities
- Alterity Therapeutics Limited (company) — Filer of the 6-K report
- March 4, 2024 (date) — Filing date of the 6-K
- Form S-8 (document) — Registration statement referenced in the filing
- Form F-3 (document) — Registration statement referenced in the filing
- Exhibit 99.1 (document) — Application for quotation of securities
FAQ
What is the purpose of this Form 6-K filing by Alterity Therapeutics Limited?
The Form 6-K is being filed to incorporate by reference an application for quotation of securities (Exhibit 99.1).
What other SEC filings are referenced in this 6-K?
This Form 6-K is incorporated by reference into Alterity Therapeutics Limited's Registration Statements on Form S-8 (Files No. 333-251073, 333-248980, and 333-228671) and Form F-3 (Files No. 333-274816, 333-251647, 333-231417, and 333-250076).
When was this Form 6-K filed?
The Form 6-K was filed on March 4, 2024.
What is the primary exhibit submitted with this 6-K?
The primary exhibit submitted is Exhibit 99.1, which is an Application for quotation of securities - ATH.
Does Alterity Therapeutics Limited file annual reports under Form 20-F or Form 40-F?
Yes, Alterity Therapeutics Limited indicates it files annual reports under Form 20-F.
Filing Stats: 192 words · 1 min read · ~1 pages · Grade level 11.2 · Accepted 2024-03-04 08:00:18
Filing Documents
- ea0201097-6k_alterity.htm (6-K) — 14KB
- ea0201097ex99-1_alterity.htm (EX-99.1) — 45KB
- ex99-1_001.jpg (GRAPHIC) — 1KB
- 0001213900-24-019252.txt ( ) — 61KB
From the Filing
OF FOREIGN PRIVATE ISSUER SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-163 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2024 Alterity Therapeutics Limited (Name of Registrant) Level 14, 350 Collins Street, Melbourne, Victoria 3000 Australia (Address of Principal Executive Office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F This Form 6-K is being incorporated by reference into our Registration Statement on Form S-8 (Files No. 333-251073 , 333-248980 and 333-228671 ) and our Registration Statements on Form F-3 (Files No. 333-274816 , 333-251647 , 333-231417 and 333-250076 ) ALTERITY THERAPEUTICS LIMITED (a development stage enterprise) The following exhibits are submitted: 99.1 Application for quotation of securities - ATH. 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Alterity Therapeutics Limited By: /s/ Geoffrey P. Kempler Geoffrey P. Kempler Chairman Date: March 4 , 2024 2